All Stories

  1. Pregnancy vs. Postpartum Breast Cancer: Distinct Tumor Biology and Survival Trends in a Contemporary Cohort
  2. Meaning, Identity, and Practice in Nipple-Areola Complex Tattooing Among Breast Cancer Survivors: A Scoping Review With a Data Mining Approach
  3. Personalized Surgical Strategies in Breast Cancer: Preliminary Evaluation of the Alexis® Retractor for Reducing Postoperative Complications and Improving Operative Efficiency
  4. A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials
  5. Can the Use of Closed Incision Negative Pressure Wound Therapy in Immediate Prepectoral Breast Reconstruction With Polyurethane-coated Implants Reduce the Rate of Early Complications? : A Comparative Study
  6. Current Evidence on Surgical Approach to Local Recurrence After Nipple-Sparing Mastectomy: Is It Time to Classify in Order to Decide Better?
  7. Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer
  8. Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM∗ study group. (∗the breast European association for mesenchymal tumors)
  9. Surgical Management of Ipsilateral Breast Cancer Recurrence After Conservative Mastectomy and Prepectoral Breast Reconstruction: Exploring the Role of Wide Local Excision
  10. Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)
  11. Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study
  12. Re-Excision After Positive Margins in Breast-Conserving Surgery: Can a Risk-Based Strategy Avoid Unnecessary Surgery?
  13. The e-BRAVE study: A prospective web-based cohort and biobank of women carriers of BRCA mutations
  14. Prepectoral Breast Reconstruction: Early and Long-term Complications and Outcomes of Total Coverage ADM and Implants vs Polyurethane-Coated Implants Without Use of Acellular Dermal Matrix
  15. Immediate Breast Reconstruction with Prepectoral Polyurethane-Covered Implant After Conservative Mastectomy in Large and Ptotic Breasts
  16. Use of membrane lipidome, body weight, and composition in stratification of early breast cancer patients
  17. Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study
  18. Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study
  19. Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort
  20. Personalizing Neoadjuvant Chemotherapy: The Impact of BRCA Variants on Pathologic Complete Response in Luminal B Breast Cancer
  21. Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors
  22. Oxidized regenerated cellulose in thoracic surgery: potential game-changer or hidden danger?
  23. Redefining conservative mastectomy: the evolution of surgical techniques
  24. Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria
  25. Personalizing Breast Cancer Surgery: Harnessing the Power of ROME (Radiological and Oncoplastic Multidisciplinary Evaluation)
  26. Oncological Safety of Prepectoral Implant-Based Breast Reconstruction After Conservative Mastectomy: Insights from 842 Consecutive Breast Cancer Patients
  27. Advancing Breast Cancer Care in Patients Aged 80 and Above: A Personalized and Multidisciplinary Management to Better Outcomes
  28. Surgery of the Primary Tumor in de novo Metastatic Breast Cancer: A Palliative Approach or a Potential Survival Game-Changer?
  29. Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy
  30. The LYMPH trial: comparing microsurgical with conservative treatment for chronic breast cancer-associated lymphoedema – study protocol of a pragmatic randomised international multicentre superiority trial
  31. Are 1 mm margins necessary after breast-conserving surgery for invasive cancer? A critical look at the proposed change
  32. Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives
  33. Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan
  34. Positive margins after breast-conserving surgery: is it possible to hang up the scalpel in the era of precision medicine?
  35. Navigating the Uncertainty of B3 Breast Lesions: Diagnostic Challenges and Evolving Management Strategies
  36. Reevaluating the promise: is primary tumor surgery really the key to survival or just a misinterpretation in de novo stage IV breast cancer?
  37. Primary tumor surgery in de novo metastatic breast cancer: Game-changer or misinterpretation?
  38. Assessing Malignant Risk in B3 Breast Lesions: Clinical Insights and Implications
  39. Advancing Breast Cancer Care in Octogenarians: A Personalized and Multidisciplinary Management to Better Outcomes
  40. Personalizing Breast Cancer Surgery: Harnessing the Power of ROME (Radiological and Oncoplastic Multidisciplinary Evaluation)
  41. The role of body composition in neurological and hematologic toxicity in a retrospective analysis of 120 breast cancer patients undergoing neoadjuvant chemotherapy: the COMBOTOX study
  42. Navigating the Uncertainty of B3 Breast Lesions: Diagnostic Challenges and Evolving Management Strategies
  43. 255P Predicting early recurrence in breast cancer patients undergoing neo-adjuvant chemotherapy through MRI-radiomics analysis
  44. Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2
  45. Fat Grafting and Prepectoral Prosthetic Reconstruction with Polyurethane-Covered Implants: Protective Role against Adjuvant Radiotherapy
  46. Outcomes of Radiotherapy in Oligoprogressive Breast Cancer
  47. Young Women with Early-Stage Breast Cancer Treated with Upfront Surgery: Overview of Oncological Outcomes
  48. Long-Term Safety of Level II Oncoplastic Surgery after Neoadjuvant Treatment for Locally Advanced Breast Cancer: A 20-Year Experience
  49. Trastuzumab Deruxtecan in brain metastases from breast cancer: outcome analysis of real life population
  50. Simultaneous Integrated Boost (Sib) Intensity-Modulated Radiotherapy for Treatment of Bone Metastases: Analysis of a Breast Cancer Cohort
  51. De-Escalation of Surgical Treatment after Neoadjuvant Chemotherapy in Breast Cancer Patients
  52. The role of body composition in neurological and hematologic toxicity in breast cancer patients undergoing neoadjuvant chemotherapy. The COMBOTOX study
  53. 133P Clinico-pathological predictors of outcome in the (neo)adjuvant setting of luminal/HER2-negative invasive lobular breast cancer (ILC)
  54. Preventing Bone Loss in Breast Cancer Patients: Designing a Personalized Clinical Pathway in a Large-Volume Research Hospital
  55. Accessible Machine Learning and Deep Learning Models Predict Response and Survival in Early Stage Hormone Receptor-Positive/HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
  56. Preventing Bone Loss in Breast Cancer Patients: Designing a Personalized Clinical Pathway in a Large-Volume Research Hospital
  57. Expanding the use of Oncoplastic Surgery in Invasive Lobular Breast Cancer: long-term results of 476 patients treated with three different surgical approaches
  58. Inflammatory breast cancer: A clinical syndrome requiring multidisciplinary management
  59. Conserving surgery in inflammatory breast cancer after neoadjuvant chemotherapy in patients with clinical complete response: the ConSIBreC randomized controlled trial
  60. The LYMPH Trial - Comparing Microsurgical with Conservative Treatment of Chronic Breast Cancer Associated Lymphedema: Study Protocol of a Pragmatic Randomized International Multicentre Superiority Trial
  61. Editorial: Methods in breast cancer
  62. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: a scoring system to predict the risk of upgrade to malignancy
  63. Use of Oxidized Regenerated Cellulose in Patients with Lung Cancer: A Biomaterial to Handle with Caution!
  64. Inflammatory breast cancer: is conservative surgery possible?
  65. 276P Development and external validation of an artificial intelligence (AI)-based machine learning model (ML) for predicting pathological complete response (pCR) in hormone-receptor (HoR)-positive/HER2-negative early breast cancer (EBC) undergoing neoa...
  66. Commentary: A lymph node mediastinal foreign body reaction mimicking nodal metastasis: a case series
  67. An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy
  68. Magnetic seed versus skin tattoo localization of non-palpable breast lesions: a single institution cohort study
  69. Tibolone and Breast Tissue: a Review
  70. Precision surgery for breast cancer: current trends and future perspectives
  71. Artificial intelligence (AI) –based machine learning models (ML) for predicting pathological complete response (pCR) in patients with hormone receptor (HoR) –positive/HER2-negative early breast cancer (EBC) undergoing neoadjuvant chemotherapy (NCT): A ...
  72. Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?
  73. 138P Activity and efficacy of neoadjuvant chemotherapy (NACT) in luminal-HER2-negative early breast cancer (EBC) according to HER2 score (low vs score 0): A retrospective study
  74. Endocrine Disruptors in Food, Estrobolome and Breast Cancer
  75. Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting
  76. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
  77. P199 Management and Outcomes of Very Young Women (≤35 Years) with Breast Cancer treated in a single Institution
  78. P231 Prepectoral versus subpectoral single stage breast reconstruction after conservative mastectomy for breast cancer: surgical and oncological outcomes
  79. Selective Axillary Dissection after Neoadjuvant Chemotherapy in Patients with Lymph-Node-Positive Breast Cancer (CLYP Study): The Radio-Guided Occult Lesion Localization Technique for Biopsy-Proven Metastatic Lymph Nodes
  80. Endocrine Disruptors in Food, Estrobolome and Breast Cancer
  81. Upfront surgery or neoadjuvant chemotherapy in young women with breast cancer: results of a retrospective cohort study
  82. Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
  83. The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer
  84. The Ultrasound Evolution of Lateral Thoracic Perforator Flaps Design and Harvest for Partial and Total Breast Reconstruction
  85. Racial and ethnic disparities in breast cancer survival: critical appraisal of the data emerging from the randomized TAILORx
  86. Paget’s disease of the breast: Our 20 years’ experience
  87. Oncoplastic Breast Surgery versus Conservative Mastectomy in the Management of Large Ductal Carcinoma In Situ (DCIS): Surgical, Oncological, and Patient-Reported Outcomes
  88. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries
  89. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer
  90. BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making
  91. Prepectoral vs. Submuscular Immediate Breast Reconstruction in Patients Undergoing Mastectomy after Neoadjuvant Chemotherapy: Our Early Experience
  92. Lymphatic Tissue Transfer: Ultrasound-Guided Description and Preoperative Planning of Vascularised Lymph Nodes, Lymphatic Units, and Lymphatic Vessels Transfers
  93. Lifestyle counselling and access to integrative treatments in Italian breast centres: Senonetwork national survey
  94. Magnetic Seed versus skin tattoo localization of non-palpable breast lesions: a single institution cohort study
  95. Editorial: Update of Current Evidences in Breast Cancer Surgery
  96. Diagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral Mammography
  97. Endocrine Disruptors in Food, Estrobolome and Breast Cancer
  98. A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer
  99. 123P Paget’s disease of the breast: Our 20-year experience
  100. 191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis
  101. Innovations in the Integrated Management of Breast Cancer
  102. Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis
  103. Vitamin D and Histological Features of Breast Cancer: Preliminary Data from an Observational Retrospective Italian Study
  104. Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience
  105. Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial
  106. Update of Current Evidences in Breast Cancer Surgery
  107. Nipple sparing mastectomy with prepectoral immediate prosthetic reconstruction without acellular dermal matrices: a single center experience
  108. Surgical treatment of breast cancer
  109. Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis
  110. Surgical management of BRCA pathogenic variant carriers with breast cancer: a recent literature review and current state of the art
  111. Techniques for sentinel node biopsy in breast cancer
  112. Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
  113. Improving Results in Oncoplastic Surgery
  114. SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study
  115. Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients
  116. Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study
  117. Breast conserving surgery using oxidized regenerated cellulose as filling biomaterial: recommendations to improve clinical outcomes
  118. Histopathological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) as Predictive Biomarker for Hormone Receptors Status, Proliferative Activity and Clinical Outcome in Her-2 Positive Breast Cancer
  119. Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
  120. How will artificial intelligence impact breast cancer research efficiency?
  121. Decision-making and technical skills to prevent local recurrence after mastectomy for pure ductal carcinoma in situ
  122. Oligometastatic Breast Cancer: How to Manage It?
  123. Letter to the Editor: critical appraisal to optimize clinical and economic impact of oxidized regenerated cellulose in surgical practice
  124. De-escalation of axillary treatment in neoadjuvant setting: recommendations for a successful work
  125. Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer
  126. Breast Cancer-Related Lymphedema: Recent Updates on Diagnosis, Severity and Available Treatments
  127. Hormone Receptor Expression Variations in Normal Breast Tissue: Preliminary Results of a Prospective Observational Study
  128. Immediate implant-based breast reconstruction with acellular dermal matrix after conservative mastectomy: can a more effective alternative be used in the near future?
  129. Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes
  130. Melanocyte Colonization and Pigmentation of Breast Carcinoma: Description of Two Pathological Cases and Review of Literature
  131. Conventional CT versus Dedicated CT Angiography in DIEP Flap Planning: A Feasibility Study
  132. Myofibroblastoma of the breast: two case reports and literature review
  133. Development of a Digital Research Assistant for the Management of Patients’ Enrollment in Oncology Clinical Trials within a Research Hospital
  134. Different Impact of Definitions of Sarcopenia in Defining Frailty Status in a Population of Older Women with Early Breast Cancer
  135. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
  136. Timing of surgery following SARS-CoV-2 infection
  137. Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis
  138. Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment
  139. Immediate Prosthetic Breast Reconstruction after Nipple-Sparing Mastectomy: Traditional Subpectoral Technique versus Direct-to-Implant Prepectoral Reconstruction without Acellular Dermal Matrix
  140. The Assisi Think Tank Meeting Breast Large Database for Standardized Data Collection in Breast Cancer—ATTM.BLADE
  141. The Key Role of Human Microbiota in Breast Cancer
  142. Image-Guided Localization Techniques for Surgical Excision of Non-Palpable Breast Lesions: An Overview of Current Literature and Our Experience with Preoperative Skin Tattoo
  143. Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach
  144. Decision-Making Skills and Performance of Standardized Tasks Can Optimize Total Operating Time in Breast Cancer Patients Undergoing Mastectomy
  145. GENERATOR Breast DataMart—The Novel Breast Cancer Data Discovery System for Research and Monitoring: Preliminary Results and Future Perspectives
  146. Acellular dermal matrix as filler in breast-conserving surgery: warnings for a careful use
  147. Racial and ethnic disparities in breast cancer survival: critical appraisal of the data emerging from the randomized TAILORx
  148. Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
  149. Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
  150. PO-0982: Preliminary analysis of radiotherapy role on PFS-2 in oligoprogressive breast cancer
  151. Mastectomy with immediate breast reconstruction during “phase 1” COVID‐19 emergency: An Italian experience
  152. Evidence-based medicine is a valuable tool for a successful decision-making on risk-reducing bilateral mastectomy
  153. Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis
  154. Compliance with Specific Recommendations and Tasks Reduces Nipple Necrosis Rates in Prepectoral Implant-Based Reconstruction After Nipple-Sparing Mastectomy
  155. 285P Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis
  156. Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
  157. Performance of standardized tasks and evidence-based surgery may increase the chance of success in breast conserving treatment
  158. The impact of the COVID‐19 pandemic on breast cancer patients awaiting surgery: Observational survey in an Italian University hospital
  159. Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review
  160. Low‐grade myofibroblastic sarcoma of the breast
  161. Transaxillary Nipple-Sparing Mastectomy and Direct-to-Implant Breast Reconstruction Using a Simplified Endoscopic Approach: Indications, Cosmetic Outcomes and Technical Refinements
  162. Actualities on Diagnosis, Targeting and Treating Bone Metastases in Breast Cancer with Radiotherapy and New Drugs
  163. Evidence-based surgery to realize a successful extreme oncoplastic breast conservation
  164. OlympiAD trial: moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer
  165. Evidence-based nipple-sparing mastectomy in patients with higher body mass index: Recommendations for a successful standardized surgery
  166. Oncoplastic Breast-Conserving Surgery
  167. Oral contraceptives and breast cancer risk: An overestimated risk?
  168. Poor efficacy of palbociclib in second‐line treatment of metastatic lobular breast cancer in a case series: Use before or never more?
  169. Menopausal hormone therapy: what should be kept in mind for a personalized choice in a shared decision-making
  170. A Rare Case of Nipple–Areolar Complex Partial Necrosis following Micropigmentation
  171. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendations to optimize the performance
  172. Results obtained with level II oncoplastic surgery spanning 20 years of breast cancer treatment: Do we really need further demonstration of reliability?
  173. Nipple‐sparing mastectomy combined with endoscopic immediate reconstruction via axillary incision for breast cancer: A preliminary experience of an innovative technique
  174. Hormone replacement therapy
  175. Oncoplastic Breast-Conserving Surgery
  176. Oncoplastic Breast Reconstruction in Conservation Surgery: Steps to Follow for a Successful Work
  177. Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients!
  178. Internal surgical use of biodegradable carbohydrate polymers. Warning for a conscious and proper use of oxidized regenerated cellulose
  179. Personalized medicine in breast cancer: a step forward
  180. Comment on “Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer”
  181. Breast-conservation Therapy After Neoadjuvant Chemotherapy
  182. Re: Oncoplastic partial breast reconstruction improves patient satisfaction and aesthetic outcome for central breast tumours
  183. Steps to follow in oncoplastic breast surgery to optimise oncological and cosmetic outcome
  184. Transaxillary Nipple-Sparing Mastectomy, Lymphadenectomy and Direct-to-Implant Submuscular Breast Reconstruction Using Endoscopic Technique
  185. Bilateral risk‐reducing mastectomy in BRCA mutation carriers: A difficult decision‐making
  186. What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers
  187. Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome
  188. Extreme oncoplastic breast conserving surgery: Is surgical dexterity all that is need?
  189. EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy
  190. The role of radiotherapy (RT) in the treatment of Adenoid Cystic Carcinoma of the Breast: case report of RT retreatment and literature review
  191. “Warning” to postoperative complications when using hemostatic agents!
  192. Abstract P1-11-03: Impact of scalp cooling device (SCD) in preventing alopecia in women undergoing chemotherapy for breast cancer
  193. What surgical oncology providers and women with sporadic breast cancer should not forget in the decision-making about contralateral prophylactic mastectomy!
  194. Contralateral prophylactic mastectomy: Warnings for a difficult decision to make with caution!
  195. The modern concept of breast conserving surgery
  196. Update of current evidences in breast cancer multidisciplinary management
  197. New techniques for sentinel node biopsy in breast cancer
  198. Current weaknesses of breast conserving strategies after neoadjuvant chemotherapy in breast cancer treatment
  199. Diagnosis and management of breast lymphoma: a single-institution retrospective analysis
  200. Taking one step backward to take two steps forward: the importance of breast tumor phenotype in MRI-based prediction of response
  201. Current controversies in the treatment of ductal carcinoma in situ of the breast
  202. New challenges in multimodal workout of locally advanced breast cancer
  203. Metastatic giant malignant phyllodes tumor of the breast
  204. Giant Malignant Phyllodes Tumor of the Breast: A Case Report
  205. Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer
  206. Mastectomy in precision oncology era: myth or reality?
  207. The Venous Lymph Node Flap: Concepts, Experimental Evidence, and Potential Clinical Implications
  208. Magnetic resonance imaging appearance of oxidized regenerated cellulose in breast cancer surgery
  209. EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series
  210. Penile cancer metastasizing to the breast: a case report
  211. Septum-based cervical lymph-node free flap in rat: a new model
  212. YB-1 in breast cancer. Our laboratory data
  213. Inverted T Skin-Reducing Mastectomy and One-Stage Immediate Implant Reconstruction
  214. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
  215. Mammographic and Ultrasonographic Findings of Oxidized Regenerated Cellulose in Breast Cancer Surgery: A 5-Year Experience
  216. Oxidized regenerated cellulose in breast surgery: experimental model
  217. AMAROS Study: Overall Survival in Breast Cancer Subtypes
  218. Contralateral Breast Symmetrisation in Immediate Prosthetic Breast Reconstruction after Unilateral Nipple-Sparing Mastectomy: The Tailored Reduction/Augmentation Mammaplasty
  219. New trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patient
  220. Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study
  221. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment
  222. Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors
  223. Oncoplastic Breast Surgery with Oxidized Regenerated Cellulose: Appraisals Based on Five-year Experience
  224. The Breast Unit and the Organization of Health Care
  225. Prognostic Role of Human Epidermal Growth Factor Receptor 2 Status in Premenopausal Early Breast Cancer Treated With Adjuvant Tamoxifen
  226. Inverted-T Skin-Reducing Mastectomy with Immediate Implant Reconstruction Using the Submuscular-Subfascial Pocket
  227. EP-0988 COMPARISON OF TWO RADIATION BOOST TECHNIQUES IN PATIENTS UNDERGOING NEOADJUVANT TREATMENT FOR BREAST CANCER
  228. 488 Comparison Between Two Radiation Planning Techniques for the Breast Boost in Patients Who Underwent Neoadjuvant Chemotherapy for Breast Cancer
  229. 466 Benefit of Different Radiation Boost Dose Based on Surgical Margins – Single-institution Experience on 2 173 Patients Treated with Radiotherapy After Breast-conserving Surgery
  230. A Feasibility Study of Neo-Adjuvant Low-Dose Fractionated Radiotherapy with Two Different Concurrent Anthracycline-Docetaxel Schedules in Stage IIA/B-IIIA Breast Cancer
  231. 776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER
  232. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness
  233. 345 Sentinel lymph node biopsy after neoadjuvant chemotherapy in locally advanced breast cancer patients: feasibility, accuracy and disease upstaging
  234. Early onset lactating adenoma and the role of breast MRI: a case report
  235. Accessory nipple reconstruction following a central quadrantectomy: a case report
  236. Breast MRI in a Case of “Early Onset” Lactating Adenoma
  237. Congenital Tumors of the Retrorectal Space in the Adult: Report of Two Cases and Review of the Literature
  238. Solid breast mass characterisation: use of the sonographic BI-RADS classification
  239. Oncoplastic Techniques in the Conservative Surgical Treatment of Breast Cancer: An Overview
  240. Gastro-intestinal symptoms as clinical manifestation of peritoneal and retroperitoneal spread of an invasive lobular breast cancer: report of a case and review of the literature
  241. Characterization of Solid Breast Masses
  242. ERRATA
  243. Conservative Treatment with Nipple-Areolar Resection for Subareolar Breast Cancer
  244. Synchronous Bilateral Breast Carcinoma in a 50-Year-Old Man with 45,X/46,XY Mosaic Karyotype: Report of a Case
  245. Synchronous Bilateral Paget's Disease of the Nipple Associated with Bilateral Breast Carcinoma
  246. Phyllodes Tumor of the Breast: Magnetic Resonance Imaging Findings and Surgical Treatment
  247. Oncoplastic techniques in the conservative surgical treatment of Breast Cancer
  248. Book Review